Literature DB >> 7283293

Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism.

M B Gordon, I Klein, A Dekker, G P Rodnan, T A Medsger.   

Abstract

A series of patients with fatal progressive systemic sclerosis was reviewed with regard to pathologic, clinical, and serologic evidence of thyroid disease. Histologic evidence of severe fibrosis of the thyroid gland was found significantly more frequently in 56 progressive systemic sclerosis cases (14%) compared to an age and sex matched control autopsy series (2%) from the same institution. Based on determination of serum free thyroxine, free triiodothyroxine (T3), thyroid stimulating hormone, and reverse T3, 27 patients were classified as euthyroid (11), euthyroid sick (9), and hypothyroid (7). Patients with hypothyroidism more frequently had subcutaneous calcinosis. Raynaud's phenomenon, esophageal hypomotility, sclerodactyly, and multiple telangiectasias (the CREST syndrome variant of progressive systemic sclerosis); all thyroid glands from the hypothyroid patients had fibrosis, but lymphocytic infiltration was an infrequent finding. Six hypothyroid patients had high titers of serum antithyroid antibodies, suggesting autoimmune thyroid disease. Thyroid gland fibrosis and hypothyroidism, possibly of autoimmune pathogenesis, are thus frequent and often unsuspected findings in progressive systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283293     DOI: 10.7326/0003-4819-95-4-431

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Thyroid function in systemic sclerosis.

Authors:  G La Montagna; C Carella; G Amato; F Filippi; G Tirri; A Bellastella
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Serum lipid profile in patients with systemic sclerosis: relationship to the thyreometabolic state.

Authors:  P J Kotyla; J Gozdzik; M Lewicki; A T Kotulska; E J Kucharz
Journal:  Rheumatol Int       Date:  2005-11-12       Impact factor: 2.631

3.  Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis.

Authors:  L De Keyser; D C Narhi; D E Furst; A K Huberman; R Ross; J Clements; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

4.  Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.

Authors:  Gian Luca Bagnato; William Neal Roberts; Alessia Fiorenza; Chiara Arcuri; Rosaria Certo; Francesco Trimarchi; Rosaria Maddalena Ruggeri; Gian Filippo Bagnato
Journal:  Endocrine       Date:  2015-05-21       Impact factor: 3.633

5.  Frequency of biochemical hypothyroidism in sera referred for autoantibody testing.

Authors:  H Reyes; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

Review 6.  Thyroid disorders in patients with progressive systemic sclerosis: a review.

Authors:  E J Kucharz
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

7.  Systemic lupus erythematosus and thyrotoxicosis: a hitherto little recognised association.

Authors:  S Rodrigué; H Laborde; P M Catoggio
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

8.  Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India.

Authors:  Pawan Kumar Singh; Shefali Khanna Sharma; Anindita Sinha; Pinaki Dutta
Journal:  Clin Rheumatol       Date:  2016-02-09       Impact factor: 2.980

9.  Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody.

Authors:  Takashi Himoto; Seiji Nakai; Fumihiko Kinekawa; Hirohito Yoneyama; Akihiro Deguchi; Kazutaka Kurokochi; Tsutomu Masaki; Shoichi Senda; Reiji Haba; Seishiro Watanabe; Mikio Nishioka; Shigeki Kuriyama
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

10.  Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

Authors:  John C Katsantonis; John Protopsaltis; Stelios Kokkoris; Paris Brestas; Kyriaki Aroni; Symeon Tournis; Gregory Giannoulis
Journal:  Rheumatol Int       Date:  2008-04-24       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.